Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorcaserin in Cocaine Use Disorder
NCT03007394Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Dec 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cocaine use disorder (CUD) comparing Lorcaserin with Placebo (2 arms). Primary endpoint: Actual Number of Subjects That Successfully Achieve Abstinence From Cocaine. Started Dec 2017; status: completed.
02
Drugs
lorcaserin
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT03007394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03007394.